Liquid chromatographic–tandem mass spectrometry assay for the quantification of MDT-637 in human nasal wash

Biomedical Chromatography

Volumn 32, Issue 9, 2018, Pages

  Karnik, Shane C ^a   Cook, Robert ^b   Gorman, Steve H ^b   Bakhtiar, Ray ^b  

^a Pyxant Labs Inc   (United States)

^b Teva Global Branded Products R and D   (United States)

Author keywords

bioanalysis; human nasal wash; LC MS MS; MDT 637; respiratory syncytial virus (RSV); supported liquid extraction (SLE)

Indexed keywords

DRUG PRODUCTS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; SOLVENT EXTRACTION; VIRUSES;

BIOANALYSIS; HUMAN NASAL WASH; LC-MS-MS; LC.MS/MS; MDT-637; METHOD VALIDATIONS; RESPIRATORY SYNCYTIAL VIRUS; SUPPORTED LIQUID EXTRACTION; SUPPORTED LIQUID EXTRACTIONS;

MASS SPECTROMETRY;

ACETONITRILE; AMMONIUM FORMATE; MDT 637; UNCLASSIFIED DRUG; VIRUS FUSION INHIBITOR;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG STABILITY; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; NASAL LAVAGE FLUID;

EID: 85053003344     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.4271     Document Type: Article

References (8)

1. DeVincenzo, J. P., Wilkinson, T., Vaishnaw, A., Cehelsky, J., Meyers, R., & Nochur, S. (2010). Viral load drives disease in humans experimentally infected with respiratory syncytial virus. American Journal of Respiratory and Critical Care Medicine, 182, 1305–1314.
2. Douglas, J. L., Panis, M. L., Ho, E., Lin, K. Y., Krawczyk, S. H., Grant, D. M., & Cihlar, T. (2003). Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein. Journal of Virology, 77, 5054–5064.
3. Food, U. S., & Administration, D. (2001). Guidance for industry: Bioanalytical method validation. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research.
4. Griffiths, C., Drews, S. J., & Marchant, D. J. (2017). Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clinical Microbiology Review, 1, 277–319.
5. Jiang, H., Jiang, X., & Ji, Q. C. (2008). Enantioselective determination of alprenolol in human plasma by liquid chromatography with tandem mass spectrometry using cellobiohydrolase chiral stationary phases. Journal of Chromatography B, 872, 121–127.
6. Jiang, H., Cao, H., Zhang, Y., & Fast, D. M. (2012). Systematic evaluation of supported liquid extraction in reducing matrix effect and improving extraction efficiency in LC–MS/MS based bioanalysis for 10 model pharmaceutical compounds. Journal of Chromatography B, 891–892, 71–80.
7. Kim, Y. I., Pareek, R., Murphy, R., Harrison, L., Farrell, E., Cook, R., & DeVincenzo, J. (2017). The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin. Influenza and Other Respiratory Viruses, 11, 525–530.
8. Wyde, P. R., Laquerre, S., Chetty, S. N., Gilbert, B. E., Nitz, T. J., & Pevear, D. C. (2005). Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol. Antiviral Research, 68, 18–26.